Cipla Ltd.

Peninsula Business Park,
Mumbai, 400013
India,
+91 22 23082891
ww.cipla.com

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 150 countries. Company portfolio includes 1,500 plus products across therapeutic categories with one quality standard globally.

M&A Summary

Buy vs Sell

Year ≤ '12 '13 '14 '15 '16 '17 T
Buy (0.6/yr) # - 1 - 2 - - 3
vol $339M $339M
Sell (0.0/yr) # - - - - - - 0
  3

Top M&A Advisors

Financial Deals
Join to Access.
Legal Deals
Join to Access.

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Enaleni Pharmaceuticals Ltd. (Medpro)
$339M (2013-02-27)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View

According to our data here at Mergr, Cipla has acquired 3 companies, including 3 in the last 5 years.

Cipla’s largest acquisition to date was in 2013, when it acquired Enaleni Pharmaceuticals for $339M. Cipla has acquired in 2 different US states, and 2 countries. The Company’s most targeted sectors include life science (67%) and distribution (34%).

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 414 life science companies that have made at least 1 acquisition, 25 have acquired at least 5 companies, and 3 have acquired more than 10 companies. The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 25 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Ampersand Capital Partners with 4 platform acquisitions.

Join Mergr and gain access to Cipla’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.3K Private Equity Firms
  • 112K M&A Transactions
  • 121K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.